Stages of pTDP-43 pathology in amyotrophic lateral sclerosis

Annals of Neurology

Volumn 74, Issue 1, 2013, Pages 20-38

  Brettschneider, Johannes ^a,b   Del Tredici, Kelly ^b   Toledo, Jon B ^a   Robinson, John L ^a   Irwin, David J ^a   Grossman, Murray ^a   Suh, Eunran ^a   Van Deerlin, Vivianna M ^a   Wood, Elisabeth M ^a   Baek, Young ^a   Kwong, Linda ^a   Lee, Edward B ^a   Elman, Lauren ^a   McCluskey, Leo ^a   Fang, Lubin ^b   Feldengut, Simone ^b   Ludolph, Albert C ^b   Lee, Virginia M Y ^a   Braak, Heiko ^b   Trojanowski, John Q ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PTDP 43 PROTEIN; TAR DNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ACCESSORY NERVE; ADULT; AGED; ALPHA NERVE FIBER; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTOPSY; BRAIN DAMAGE; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE SEVERITY; FACIAL NERVE; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOGLOSSAL NERVE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MIDDLE FRONTAL GYRUS; MOTONEURON NUCLEUS; MOTOR CORTEX; NEOCORTEX; NEUROPATHOLOGY; OLIGODENDROGLIA; OPEN READING FRAME; ORBITAL CORTEX; PRECEREBELLAR NUCLEUS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; RED NUCLEUS; RETICULAR FORMATION; SPINAL CORD; TEMPORAL LOBE; TISSUE SECTION; TRIGEMINAL NERVE; VAGUS NERVE;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN; CELL CYCLE PROTEINS; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; DNA-BINDING PROTEINS; FEMALE; GENETIC TESTING; HUMANS; MALE; MIDDLE AGED; MUTATION; NEUROGLIA; NEURONS; PROTEINS; SPINAL CORD; TDP-43 PROTEINOPATHIES; UBIQUITINS;

EID: 84883292041     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23937     Document Type: Article

References (88)

1. Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet 2011; 377: 942-955.
2. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130-133.
3. Lee EB, Lee VM, Trojanowski JQ,. Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci 2012; 13: 38-50.
4. Braak H, Thal DR, Ghebremedhin E, Del Tredici K,. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 2011; 70: 960-969.
5. Braak H, Del Tredici K,. Where, when, and in what form does sporadic Alzheimer's disease begin? Curr Opin Neurol 2012; 25: 708-714.
6. Braak H, Del Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003; 24: 197-211.
7. Polymenidou M, Cleveland DW,. Prion-like spread of protein aggregates in neurodegeneration. J Exp Med 2012; 209: 889-893.
8. Clavaguera F, Bolmont T, Crowther RA, et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 2009; 11: 909-913.
9. Li JY, Englund E, Holton JL, et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 2008; 14: 501-503.
10. Mougenot AL, Bencsik A, Nicot S, et al. Transmission of prion strains in a transgenic mouse model overexpressing human A53T mutated alpha-synuclein. J Neuropathol Exp Neurol 2011; 70: 377-385.
11. Volpicelli-Daley LA, Luk KC, Patel TP, et al. Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron 2011; 72: 57-71.
12. Luk KC, Kehm VM, Zhang B, et al. Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J Exp Med 2012; 209: 975-986.
13. Luk KC, Kehm V, Carroll J, et al. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012; 338: 949-953.
14. Cushman M, Johnson BS, King OD, et al. Prion-like disorders: blurring the divide between transmissibility and infectivity. J Cell Sci 2010; 123 (pt 8): 1191-1201.
15. Brooks BR, Miller RG, Swash M, Munsat TL,. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293-299.
16. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (phase III). J Neurol Sci 1999; 169: 13-21.
17. Folstein MF, Folstein SE, McHugh PR,. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
18. Xie SX, Baek Y, Grossman M, et al. Building an integrated neurodegenerative disease database at an academic health center. Alzheimers Dement 2011; 7: e84-e93.
19. Kanouchi T, Ohkubo T, Yokota T,. Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation? J Neurol Neurosurg Psychiatry 2012; 83: 739-745.
20. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998; 51: 1546-1554.
21. Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011; 134 (pt 9): 2456-2477.
22. Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology 2011; 76: 1006-1014.
23. Duda JE, Giasson BI, Mabon ME, Lee VM, Trojanowski JQ,. Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Annals of neurology 2002; 52: 205-10.
24. Neumann M, Kwong LK, Lee EB, et al. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol 2009; 117: 137-149.
25. Lee EB, Leng LZ, Zhang B, et al. Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice. J Biol Chem 2006; 281: 4292-4299.
26. Uryu K, Nakashima-Yasuda H, Forman MS, et al. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 2008; 67: 555-564.
27. Geser F, Brandmeir NJ, Kwong LK, et al. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol 2008; 65: 636-641.
28. Feldengut S, Del Tredici K, Braak H,. Paraffin sections of 70-100 μm: a novel technique and its benefits for studying the nervous system. J Neurosci Methods 2013; 215: 241-244.
29. Brettschneider J, Van Deerlin VM, Robinson JL, et al. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion. Acta Neuropathol 2012; 123: 825-839.
30. Deng HX, Chen W, Hong ST, et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 2011; 477: 211-215.
31. Van Deerlin VM, Leverenz JB, Bekris LM, et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol 2008; 7: 409-416.
32. Braak H, Rüb U, Del Tredici K,. Involvement of precerebellar nuclei in multiple system atrophy. Neuropathol Appl Neurobiol 2003; 29: 60-76.
33. Braak H, Braak E,. Neuronal types in the striatum of man. Cell Tissue Res 1982; 227: 319-342.
34. Schmidt S, Braak E, Braak H,. Parvalbumin-immunoreactive structures of the adult human entorhinal and transentorhinal region. Hippocampus 1993; 3: 459-470.
35. Braak H, Braak E,. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-259.
36. Ozawa T, Paviour D, Quinn NP, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. Brain 2004; 127 (pt 12): 2657-2671.
37. Ravits JM, La Spada AR,. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 2009; 73: 805-811.
38. Ravits J, Paul P, Jorg C,. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology 2007; 68: 1571-1575.
39. Ravits J, Laurie P, Fan Y, et al. Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem. Neurology 2007; 68: 1576-1582.
40. Mori F, Tanji K, Zhang HX, et al. Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia. Acta neuropathologica 2008; 116: 193-203.
41. Nishihira Y, Tan CF, Hoshi Y, et al. Sporadic amyotrophic lateral sclerosis of long duration is associated with relatively mild TDP-43 pathology. Acta Neuropathol 2009; 117: 45-53.
42. Brettschneider J, Libon DJ, Toledo JB, et al. Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis. Acta Neuropathol 2012; 123: 395-407.
43. Mori F, Tanji K, Zhang HX, et al. Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol 2008; 116: 193-203.
44. Lee Y, Morrison BM, Li Y, et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 2012; 487: 443-448.
45. Philips T, Bento-Abreu A, Nonneman A, et al. Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis. Brain 2013; 136 (pt 2): 471-482.
46. Mackenzie IR, Bigio EH, Ince PG, et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 2007; 61: 427-434.
47. Hirano A,. Neuropathology of ALS: an overview. Neurology 1996; 47 (4 suppl 2): S63-S66.
48. Al-Chalabi A, Jones A, Troakes C, et al. The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol 2012; 124: 339-352.
49. Okamoto K, Hirai S, Amari M, et al. Oculomotor nuclear pathology in amyotrophic lateral sclerosis. Acta Neuropathol 1993; 85: 458-462.
50. Lawyer T Jr, Netsky MG,. Amyotrophic lateral sclerosis. AMA Arch Neurol Psychiatry 1953; 69: 171-192.
51. Sharma R, Hicks S, Berna CM, et al. Oculomotor dysfunction in amyotrophic lateral sclerosis: a comprehensive review. Arch Neurol 2011; 68: 857-861.
52. Büttner-Ennever JA,. The extraocular motor nuclei: organization and functional neuroanatomy. Prog Brain Res 2006; 151: 95-125.
53. Suzuki L, Coulon P, Sabel-Goedknegt EH, Ruigrok TJ,. Organization of cerebral projections to identified cerebellar zones in the posterior cerebellum of the rat. J Neurosci 2012; 32: 10854-10869.
54. Gilbert RM, Fahn S, Mitsumoto H, Rowland LP,. Parkinsonism and motor neuron diseases: twenty-seven patients with diverse overlap syndromes. Mov Disord 2010; 25: 1868-1875.
55. Donaghy C, Thurtell MJ, Pioro EP, et al. Eye movements in amyotrophic lateral sclerosis and its mimics: a review with illustrative cases. J Neurol Neurosurg Psychiatry 2011; 82: 110-116.
56. Leveille A, Kiernan J, Goodwin JA, Antel J,. Eye movements in amyotrophic lateral sclerosis. Arch Neurol 1982; 39: 684-686.
57. Phukan J, Pender NP, Hardiman O,. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol 2007; 6: 994-1003.
58. Strong MJ, Grace GM, Orange JB, et al. A prospective study of cognitive impairment in ALS. Neurology 1999; 53: 1665-1670.
59. Jeong Y, Park KC, Cho SS, et al. Pattern of glucose hypometabolism in frontotemporal dementia with motor neuron disease. Neurology 2005; 64: 734-736.
60. Ludolph AC, Langen KJ, Regard M, et al. Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand 1992; 85: 81-89.
61. Fang PC, Stepniewska I, Kaas JH,. Ipsilateral cortical connections of motor, premotor, frontal eye, and posterior parietal fields in a prosimian primate, Otolemur garnetti. J Comp Neurol 2005; 490: 305-333.
62. Wu CW, Bichot NP, Kaas JH,. Converging evidence from microstimulation, architecture, and connections for multiple motor areas in the frontal and cingulate cortex of prosimian primates. J Comp Neurol 2000; 423: 140-177.
63. Matsumura M, Kubota K,. Cortical projection to hand-arm motor area from post-arcuate area in macaque monkeys: a histological study of retrograde transport of horseradish peroxidase. Neurosci Lett 1979; 11: 241-246.
64. Muakkassa KF, Strick PL,. Frontal lobe inputs to primate motor cortex: evidence for four somatotopically organized 'premotor' areas. Brain Res 1979; 177: 176-182.
65. Tokuno H, Tanji J,. Input organization of distal and proximal forelimb areas in the monkey primary motor cortex: a retrograde double labeling study. J Comp Neurol 1993; 333: 199-209.
66. Lu MT, Preston JB, Strick PL,. Interconnections between the prefrontal cortex and the premotor areas in the frontal lobe. J Comp Neurol 1994; 341: 375-392.
67. Piao YS, Wakabayashi K, Kakita A, et al. Neuropathology with clinical correlations of sporadic ayotrophic lateral sclerosis: 102 autopsy cases examined between 1962 and 2000. Brain Pathol 2003; 13: 10-22.
68. Matheson JK, Harrington HJ, Hallett M,. Abnormalities of multimodality evoked potentials in amyotrophic lateral sclerosis. Arch Neurol 1986; 43: 338-340.
69. Radtke RA, Erwin A, Erwin CW,. Abnormal sensory evoked potentials in amyotrophic lateral sclerosis. Neurology 1986; 36: 796-801.
70. Thiebaut de Schotten M, Dell'Acqua F, Valabregue R, Catani M,. Monkey to human comparative anatomy of the frontal lobe association tracts. Cortex 2012; 48: 82-96.
71. Kawamura K, Naito J,. Corticocortical projections to the prefrontal cortex in the rhesus monkey investigated with horseradish peroxidase techniques. Neurosci Res 1984; 1: 89-103.
72. Zhang H, Tan CF, Mori F, et al. TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol 2008; 115: 115-122.
73. Miki Y, Mori F, Nunomura J, et al. Sporadic amyotrophic lateral sclerosis with pallido-nigro-luysian degeneration: a TDP-43 immunohistochemical study. Neuropathology 2010; 30: 149-153.
74. Nambu A,. A new dynamic model of the cortico-basal ganglia loop. Prog Brain Res 2004; 143: 461-466.
75. Saper CB,. Role of the cerebral cortex and striatum in emotional motor response. Prog Brain Res 1996; 107: 537-550.
76. Boxer AL, Mackenzie IR, Boeve BF, et al. Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family. J Neurol Neurosurg Psychiatry 2011; 82: 196-203.
77. Kew JJ, Leigh PN, Playford ED, et al. Cortical function in amyotrophic lateral sclerosis. A positron emission tomography study. Brain 1993; 116 (pt 3): 655-680.
78. Lee SJ, Desplats P, Sigurdson C, et al. Cell-to-cell transmission of non-prion protein aggregates. Nat Rev Neurol 2010; 6: 702-706.
79. Baker HF, Ridley RM, Duchen LW, et al. Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy. Mol Neurobiol 1994; 8: 25-39.
80. Kane MD, Lipinski WJ, Callahan MJ, et al. Evidence for seeding of beta-amyloid by intracerebral infusion of Alzheimer brain extracts in beta-amyloid precursor protein-transgenic mice. J Neurosci 2000; 20: 3606-3611.
81. Mougenot AL, Nicot S, Bencsik A, et al. Prion-like acceleration of a synucleinopathy in a transgenic mouse model. Neurobiol Aging 2012; 33: 2225-2228.
82. Nath S, Agholme L, Kurudenkandy FR, et al. Spreading of neurodegenerative pathology via neuron-to-neuron transmission of beta-amyloid. J Neurosci 2012; 32: 8767-8777.
83. Chia R, Tattum MH, Jones S, et al. Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis. PloS One 2010; 5: e10627.
84. Furukawa Y, Kaneko K, Watanabe S, et al. A seeding reaction recapitulates intracellular formation of sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions. J Biol Chem 2011; 286: 18664-18672.
85. Fallini C, Bassell GJ, Rossoll W,. The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth. Hum Mol Genet 2012; 21: 3703-3718.
86. Dejesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS. Neuron 2011; 72: 245-256.
87. Renton AE, Majounie E, Waite A, et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron 2011; 72: 257-268.
88. Byrne S, Elamin M, Bede P, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet neurology 2012; 11: 232-240.